CD

Smokeless Tobacco

search

Smokeless Tobacco, Chewing Tobacco, Tobacco Chew

  • See Also
  1. Tobacco
  2. Tobacco Cessation
  3. Vaping
  • Epidemiology
  1. Prevalence: U.S.
    1. Adults: 5 Million (2.1%) total, 4.2% of men in U.S.)
    2. Most common in midwest and south (esp. West Virginia, Wyoming, Montana and Mississippi)
  2. Race
    1. Most common in non-hispanic white patients
  3. Gender
    1. Males
      1. Men: 4.2%
      2. Boys: 1.0% middle school, 2.3% high school
    2. Females
      1. Women: 0.2%
      2. Girls: 0.7% middle school, 0.6% high school
  • Risk Factors
  1. Uninsured
  2. Mental health disorders
  • Complications
  1. Cerebrovascular Accident
  2. Esophageal Cancer
  3. Latyngeal Cancer
  • Management
  1. See Tobacco Cessation
  2. Most effective measures for smokeless Tobacco Cessation
    1. Tobacco Cessation Counseling (even brief clinic-based measures)
    2. Nicotine Replacement therapy
    3. Varenicline (Chantix)
  3. Other measures which do not appear effective in smokeless Tobacco Cessation
    1. Bupropion (Zyban, Wellbutrin)
  • Resources
  1. Smokeless Tobacco Product Use in the United States (CDC)
    1. https://www.cdc.gov/tobacco/other-tobacco-products/smokeless-product-use-in-the-us.html
  • References
  1. Livingstone-Banks (2025) Cochrane Database Syst Rev 4(4):CD015314 +PMID: 40232040 [PubMed]